Mawer Investment Management Ltd. Organon & Co. Transaction History

Mawer Investment Management Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$16.59 - $23.77 $5.74 Million - $8.22 Million	-345,921 Reduced 2.62%	12,847,934 $223 Million
Q2 2023 Aug 09, 2023	SELL	$19.27 - $24.63 $1.56 Million - $1.99 Million	-80,795 Reduced 0.61%	13,193,855 $275 Million
Q1 2023 May 05, 2023	BUY	$21.42 - $32.08 $2.03 Million - $3.04 Million	94,845 Added 0.72%	13,274,650 $312 Million
Q4 2022 Feb 07, 2023	BUY	$23.31 - $28.61 $55.5 Million - $68.1 Million	2,381,668 Added 22.06%	13,179,805 $368 Million
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $1.18 Million - $1.73 Million	-50,385 Reduced 0.46%	10,798,137 $253 Million
Q2 2022 Aug 09, 2022	BUY	$31.66 - $38.9 $80.8 Million - $99.3 Million	2,553,301 Added 30.78%	10,848,522 $366 Million
Q1 2022 May 06, 2022	BUY	$30.45 - $39.36 $253 Million - $326 Million	8,295,221 New	8,295,221 $290 Million

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mawer Investment Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Mawer Investment Management Ltd. with notifications on news.